Levothyroxine Supplementation Following Hemithyroidectomy: Incidence, Risk Factors, and Characteristics

被引:13
作者
Ahn, Dongbin [1 ]
Lee, Gil Joon [1 ]
Sohn, Jin Ho [1 ]
机构
[1] Kyungpook Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Daegu, South Korea
关键词
DIFFERENTIATED THYROID-CANCER; HORMONE SUPPLEMENTATION; ASSOCIATION GUIDELINES; HYPOTHYROIDISM; DISEASE; SUPPRESSION; REPLACEMENT; MANAGEMENT;
D O I
10.1245/s10434-019-07786-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The goal of the present study was to determine the actual incidence, predictive risk factors, and clinical characteristics of levothyroxine supplementation (LT4S) used for the management of hypothyroidism after hemithyroidectomy. Methods. From 2008 to 2015, we included 535 patients who underwent hemithyroidectomy. LT4S was initiated based on three major criteria: the development of overt hypothyroidism, subclinical hypothyroidism with thyroid-stimulating hormone (TSH) levels > 10 mIU/L, or subclinical hypothyroidism with TSH levels of 4.5-10 mIU/L with associated signs/symptoms. Results. During the 69-month follow-up period, 321 patients (60%) developed overall hypothyroidism following hemithyroidectomy, and 141 ultimately required LT4S, with an overall LT4S incidence of 26.4%. The most common cause of LT4S initiation was subclinical hypothyroidism with TSH levels > 10 mIU/L. In 141 patients with LT4S, the mean maintenance dose of levothyroxine was 1.34 lg/kg, and only 6 patients (4.3%) discontinued LT4S during the follow-up. The 1-, 3-, 5-, and 7-year LT4S-free survival rates of 535 patients were 88.6%, 80.2%, 73.8%, and 69.1%, respectively. Preoperative TSH levels > 2.12 mIU/L and coexistence of Hashimoto's thyroiditis were significantly associated with LT4S following hemithyroidectomy. The risk of LT4S increased by 1.401 times, as preoperative TSH levels increased by 1 mIU/L. Discussion. A quarter of patients required LT4S after hemithyroidectomy for the management of hypothyroidism, with a mean maintenance levothyroxine dose of 1.34 lg/kg. The preoperative TSH level and coexistence of Hashimoto's thyroiditis were significant predictive factors of LT4S following hemithyroidectomy.
引用
收藏
页码:4405 / 4413
页数:9
相关论文
共 26 条
  • [1] Hypothyroidism Following Hemithyroidectomy: Incidence, Risk Factors, and Clinical Characteristics
    Ahn, Dongbin
    Sohn, Jin Ho
    Jeon, Jae Han
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04) : 1429 - 1436
  • [2] [Anonymous], 2018, NCCN Clinical Practice Guidelines in Oncology
  • [3] OVERALL AND CAUSE-SPECIFIC SURVIVAL FOR PATIENTS UNDERGOING LOBECTOMY, NEAR-TOTAL, OR TOTAL THYROIDECTOMY FOR DIFFERENTIATED THYROID CANCER
    Barney, Brandon M.
    Hitchcock, Ying J.
    Sharma, Pramod
    Shrieve, Dennis C.
    Tward, Jonathan D.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (05): : 645 - 649
  • [4] Extent of surgery affects survival for papillary thyroid cancer
    Bilimoria, Karl Y.
    Bentrem, David J.
    Ko, Clifford Y.
    Stewart, Andrew K.
    Winchester, David P.
    Talamonti, Mark S.
    Sturgeon, Cord
    [J]. ANNALS OF SURGERY, 2007, 246 (03) : 375 - 384
  • [5] Thyrotropin suppressive therapy in thyroid carcinoma: What are the targets?
    Brabant, G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) : 1167 - 1169
  • [6] Subclinical thyroid disease - Clinical applications
    Col, NF
    Surks, MI
    Daniels, GH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (02): : 239 - 243
  • [7] Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry
    Cooper, DS
    Specker, B
    Ho, M
    Sperling, M
    Ladenson, PW
    Ross, DS
    Ain, KB
    Bigos, ST
    Brierley, JD
    Haugen, BR
    Klein, I
    Robbins, J
    Sherman, SI
    Taylor, T
    Maxon, HR
    [J]. THYROID, 1998, 8 (09) : 737 - 744
  • [8] Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines?
    Cox, Caroline
    Bosley, Maggie
    Southerland, Lori Beth
    Ahmadi, Sara
    Perkins, Jennifer
    Roman, Sanziana
    Sosa, Julie Ann
    Carneiro-Pla, Denise
    [J]. SURGERY, 2018, 163 (01) : 75 - 79
  • [9] Thyroid Stimulating Hormone Suppression in the Long-term Follow-up of Differentiated Thyroid Cancer
    Freudenthal, B.
    Williams, G. R.
    [J]. CLINICAL ONCOLOGY, 2017, 29 (05) : 325 - 328
  • [10] The Effect of Levothyroxine Discontinuation Timing on Postoperative Hypothyroidism after Hemithyroidectomy for Papillary Thyroid Microcarcinoma
    Ha, Tae Kwun
    Kim, Dong Wook
    Park, Ha Kyoung
    Baek, Jin Wook
    Lee, Yoo Jin
    Park, Young Mi
    Kim, Do Hun
    Jung, Soo Jin
    Ahn, Ki Jung
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016